Xuejie Jiang
7PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.Yu Zhang, Zinan Feng, Jing Du
|Nov 22, 2024
Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia-related mutations in first remission.Ling Jiang, Jiaying Cheng, Junya Sun
|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.Guopan Yu, Yu Zhang, Sijian Yu
|Aug 10, 2024
Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients.Quan Wu, Yujiao Zhang, Baoyi Yuan
|Mar 21, 2021
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.Xuejie Jiang, Ling Jiang, Jiaying Cheng
|Oct 25, 2019
Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation.Fang Chen, Junya Sun, Changxin Yin
Pageof 2
